Literature DB >> 16415008

Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.

Eduardo O'Neill1, Lillian S Kuo, John F Krisko, Diana R Tomchick, J Victor Garcia, John L Foster.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) early gene product Nef is a multifunctional protein that alters numerous pathways of T-cell function, including endocytosis, signal transduction, vesicular trafficking, and immune modulation, and is a major determinant of pathogenesis. Individual Nef functions include PAK-2 activation, CD4 downregulation, major histocompatibility complex (MHC) class I downregulation, and enhancement of viral particle infectivity. How Nef accomplishes its multiple tasks presents a difficult problem of mechanistic analysis because of the complications associated with multiple, overlapping functional domains in the context of significant sequence variability. To address these issues we determined the conservation of each Nef residue based on 1,643 subtype B Nef sequences. Mutational analysis based on conservative substitutions and Nef sequence data allowed us to search for amino acids on the surface of Nef that are specifically required for PAK-2 activation. We found residues 85, 89, and 191 to be highly significant determinants for Nef's PAK-2 activation function but functionally unlinked to CD4 and MHC class I downregulation or enhancement of infectivity. These residues are not conserved across HIV-1 subtypes but are confined to separate sets of surface elements within a subtype. Thus, L85/H89/F191 and F85/F89/R191 are dominant in subtype B and subtype E or C, respectively. Our results provide support for developing subtype-specific interventions in HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415008      PMCID: PMC1346962          DOI: 10.1128/JVI.80.3.1311-1320.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques.

Authors:  S M Lang; A J Iafrate; C Stahl-Hennig; E M Kuhn; T Nisslein; F J Kaup; M Haupt; G Hunsmann; J Skowronski; F Kirchhoff
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

2.  Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques.

Authors:  E T Sawai; I H Khan; P M Montbriand; B M Peterlin; C Cheng-Mayer; P A Luciw
Journal:  Curr Biol       Date:  1996-11-01       Impact factor: 10.834

3.  HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis.

Authors:  M Wiskerchen; C Cheng-Mayer
Journal:  Virology       Date:  1996-10-01       Impact factor: 3.616

4.  Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling.

Authors:  A J Iafrate; S Bronson; J Skowronski
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

Review 5.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

6.  Refined solution structure and backbone dynamics of HIV-1 Nef.

Authors:  S Grzesiek; A Bax; J S Hu; J Kaufman; I Palmer; S J Stahl; N Tjandra; P T Wingfield
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

7.  Infectivity enhancement by human immunodeficiency virus type 1 Nef is independent of its association with a cellular serine/threonine kinase.

Authors:  T Luo; R A Livingston; J V Garcia
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase.

Authors:  A S Baur; G Sass; B Laffert; D Willbold; C Cheng-Mayer; B M Peterlin
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

9.  Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature-sensitive for CD4 downregulation.

Authors:  C Aiken; L Krause; Y L Chen; D Trono
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

10.  A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity.

Authors:  E T Sawai; A S Baur; B M Peterlin; J A Levy; C Cheng-Mayer
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

View more
  52 in total

1.  HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.

Authors:  Weihua Li; Chuanyun Li; Wei Xia; Xiuhui Li
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.

Authors:  Giulia Matusali; Marina Potestà; Angela Santoni; Cristina Cerboni; Margherita Doria
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  The Evolving Profile of the Signature Amino Acid Residues in HIV-1 Subtype C Tat.

Authors:  Shambhu Prasad G Aralaguppe; Shilpee Sharma; Malini Menon; Vinayaka R Prasad; Shanmugam Saravanan; Kailapuri G Murugavel; Suniti Solomon; Udaykumar Ranga
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02-09       Impact factor: 2.205

4.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

5.  A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2.

Authors:  O Wolf Lindwasser; William J Smith; Rittik Chaudhuri; Peter Yang; James H Hurley; Juan S Bonifacino
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

6.  Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1.

Authors:  Art F Y Poon; Luke C Swenson; Winnie W Y Dong; Wenjie Deng; Sergei L Kosakovsky Pond; Zabrina L Brumme; James I Mullins; Douglas D Richman; P Richard Harrigan; Simon D W Frost
Journal:  Mol Biol Evol       Date:  2009-12-02       Impact factor: 16.240

7.  Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor.

Authors:  Ronald P Trible; Lori Emert-Sedlak; Thomas E Wales; Velpandi Ayyavoo; John R Engen; Thomas E Smithgall
Journal:  J Mol Biol       Date:  2007-09-11       Impact factor: 5.469

8.  Development and validation of a high-content bimolecular fluorescence complementation assay for small-molecule inhibitors of HIV-1 Nef dimerization.

Authors:  Jerrod A Poe; Laura Vollmer; Andreas Vogt; Thomas E Smithgall
Journal:  J Biomol Screen       Date:  2013-11-26

9.  Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Authors:  Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

10.  Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.

Authors:  Shailendra K Saxena; Gaurav Shrivastava; Sneham Tiwari; Ml Arvinda Swamy; Madhavan Pn Nair
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.